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Abstract 9 
Fumonisin B1 (FB1) and beauvericin (BEA) are secondary metabolites of filamentous 10 
fungi, which under appropriate temperature and humidity conditions may develop on 11 
various foods and feeds. To date few studies have been performed to evaluate the 12 
toxicological and endocrine disrupting effects of FB1 and BEA. The present study 13 
makes use of various in vitro bioassays including; oestrogen, androgen, progestagen and 14 
glucocorticoid reporter gene assays (RGAs) for the study of nuclear receptor 15 
transcriptional activity, the thiazolyl blue tetrazolium bromide (MTT) assay to monitor 16 
cytotoxicity and high content analysis (HCA) for the detection of pre-lethal toxicity in 17 
the RGA and Caco-2 human colon adenocarcinoma cells.  18 
At the receptor level, 0.001-10 M BEA or FB1 did not induce any agonist responses in 19 
the RGAs. However at non-cytotoxic concentrations, an antagonistic effect was 20 
exhibited by FB1 on the androgen nuclear receptor transcriptional activity at 10 μM and 21 
BEA on the progestagen and glucocorticoid receptors at 1 μM. MTT analysis showed 22 
no decrease in cell viability at any concentration of FB1, whereas BEA showed a 23 
significant decrease in viability at 10 μM. HCA analysis confirmed that the reduction in 24 
the progestagen receptor transcriptional activity at 1 M BEA was not due to pre-lethal 25 
toxicity. In addition, BEA (10 μM) induced significant toxicity in both the TM-Luc 26 
(progestagen responsive) and Caco-2 cells.  27 
Keywords: Mycotoxin, Beauvericin, Fumonisin B1, Reporter gene assay, High 28 
Content Analysis. 29 
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1. Introduction  30 
Mycotoxins are secondary metabolites of filamentous fungi, which under 31 
appropriate temperature and humidity conditions may develop on various foods and 32 
feeds. They are mainly produced by fungi belonging to the genera Aspergillus, 33 
Penicillium, Fusarium, Alternaria and Claviceps (Fung et al., 2004).  Fusarium species 34 
are contaminants of wheat, maize, and other grains worldwide, capable of producing 35 
high levels of fumonisin mycotoxins. Fumonisin B1 (FB1) is the most prevalent of the 36 
fumonisins, accounting for approximately 70% of total fumonisins (Martins et al., 37 
2012). Studies have also highlighted that Fusarium species can co-produce other 38 
mycotoxins such as Beauvericin (BEA) simultaneously (Dombrink-Kurtzman, 2003). 39 
Total fumonisin concentrations in feed materials have been reported to vary from a 40 
few μg/kg to tens of mg/kg (EFSA, 2005). Dietary fumonisin estimates, by the Food 41 
and Agriculture Organization of the United Nations and World Health Organization 42 
(FAO/WHO, 2001), indicate exposure levels ranging from 0.02-0.2 μg/kg in body 43 
weight (b.w.)/day, thus remaining below the Tolerable Daily Intake (TDI) of 2 μg/kg 44 
b.w./day as set in Europe by the Scientific Committee on Food (SCF, 2003). 45 
Nevertheless, a wide range of animal diseases and pathophysiological effects such as 46 
leukoencephalomalacia, porcine pulmonary oedema, liver and kidney toxicity and liver 47 
cancer, as well as human oesophageal carcinoma are associated with FB1 ingestion 48 
(Harrison et al., 1990; Kellerman et al., 1990; Gelderblom et al., 1997; Hussein et al., 49 
2001). While the molecular mechanism of FB1 toxicity is poorly understood, it appears 50 
to be related to the deregulation of sphingolipid metabolism (Merrill et al., 2001).  51 
 BEA is predominantly found in cereal grains such as wheat, maize and rice 52 
(Serrano et al., 2012) as well as other matrices such as nuts and dried fruits (Tolosa et 53 
al., 2013). The mean dietary exposure to BEA varies from a minimum of 0.003 μg/kg 54 
b.w./day to a maximum of 0.050 μg/kg b.w./day (EFSA, 2014). However, the Panel on 55 
Contaminants in the Food Chain (CONTAM) concluded that there was insufficient data 56 
to establish a TDI or/and an acute reference dose (ARfD) for BEA in humans (EFSA, 57 
2014). BEA possesses a wide range of biological activities. These substances are known 58 
as ionophores, forming a complex with essential cations (Ca2+, Na+, K+), which 59 
increases ion permeability of biological membranes, therefore potentially affecting ionic 60 
homeostasis (Chen et al., 2006). Many mycotoxins such as ochratoxin A, patulin, 61 
alternariol and zearalenone have been found to possess endocrine disrupting capabilities 62 
(Frizzell et al., 2011, 2013a, 2013b and 2014). 63 
 Endocrine disruptors (EDs) include both natural and man-made substances that 64 
may interfere with the body’s endocrine system by acting like endogenous hormones 65 
and inducing adverse developmental, reproductive, neurological and immune effects 66 
(IPCS, 2002). A few studies suggest that FB1 may act as a potential ED (Collins et al., 67 
1998; Gbore et al., 2009). While there is not enough data to confirm that FB1 is a 68 
developmental or reproductive toxicant in animals or humans, Collins et al., (1998) 69 
reported that FB1 was toxic to maternal rats and the foetus at 15 mg/kg of feed 70 
consumption. In addition, Gbore (2009) reported that FB1 affected fertility in pigs by 71 
causing a delay in sexual maturity and poor sperm production and quality. There are no 72 
in vivo toxicological studies available on reproduction and developmental toxicity, 73 
neurotoxicity or carcinogenicity for BEA. However, it has been shown to be absorbed 74 
and rapidly metabolised to a range of uncharacterised metabolites as detected in the 75 
eggs of laying hens and several tissues of turkeys and broilers (Jestoi, 2008).  76 
 In vitro bioassays may be used to investigate the toxicity and endocrine disrupting 77 
potential of compounds (Connolly et al., 2011). The emerging technology, High 78 
Content Analysis (HCA) is a highly powerful multi-parameter bio-analytical based tool 79 
incorporating fluorescent microscopy with automated in vitro cell analysis software. 80 
HCA provides assays with high sensitivity and specificity for pre-lethal cytotoxicity and 81 
multiple biological endpoints for use as a high throughput-screening tool to monitor the 82 
cytotoxicity, endocrine disruption and biological effects of compounds on exposed cells 83 
(Clarke et al., 2015).  84 
In this study, we have investigated the endocrine disrupting and cytotoxic 85 
potential of FB1 and BEA using various in vitro bioassays. Reporter gene assays 86 
(RGAs) utilising human mammary gland cells with natural steroid hormone receptors 87 
for oestrogens, androgens, progestagens and glucocorticoids (Willemsen et al., 2004) 88 
are employed for the identification of endocrine disruption at the level of nuclear 89 
receptor transcriptional activity. HCA is used to detect early cytotoxicity, via multiple 90 
markers in the progestagen responsive (TM-Luc) cell line exposed to 0.001-10 μM 91 
BEA, to ensure that a reduction in transcriptional activation of endocrine receptors is 92 
not correlated with pre-lethal toxicity. HCA is also used to assess cytotoxicity in colon 93 
adenocarcinoma (Caco-2) cells because the ingestion of food contaminated with FB1 94 
and BEA is the main exposure route for animals and humans.   95 
 96 
 97 
2. Materials and methods  98 
2.1 Reagents  99 
Methanol, thiazolyl blue tetrazolium bromide (MTT), FB1, BEA and the steroid 100 
hormones 17β-estradiol, testosterone, progesterone and hydrocortisone were obtained 101 
from Sigma–Aldrich (Poole, Dorset, UK). Cell culture reagents were obtained from Life 102 
Technologies (Paisley, UK). Multiparameter cytotoxicity 2 multiplex kit (8400202) 103 
containing mitochondrial probe and cell membrane permeability dye was supplied by 104 
Thermo Scientific, UK. Stock solutions of FB1 and BEA were prepared in methanol 105 
and stored at -20ºC. FB1 and BEA were dissolved in methanol at a final concentration 106 
of 0.5% (v/v) in media for the RGAs, MTT assays and HCA. 107 
 108 
2.2 Cell culture  109 
All cells were routinely cultured in 75 cm2 tissue culture flasks (Nunc, Roskilde, 110 
Denmark) at 37 ° with 5% CO2 and 95% humidity.  111 
Four RGA cell lines were previously developed by the transformation of human 112 
mammary gland cells with the luciferase gene under the control of a steroid hormone 113 
inducible promoter (Willemsen et al., 2004). The MMV-Luc cell is specific for the 114 
detection of oestrogens, TARM-Luc for androgens and progestagens, TM-Luc for 115 
progestagens and TGRM-Luc for glucocorticoids and progestagens. The RGA cells 116 
were routinely grown in cell culture medium containing Dulbecco’s Modified Eagle 117 
Medium (DMEM), 10% foetal bovine serum (FBS) and 1% penicillin streptomycin. As 118 
phenol red is a weak oestrogen, DMEM without phenol red was used when culturing the 119 
MMV-Luc cells. Cells were transferred prior to RGA analysis into assay media, which 120 
was composed of DMEM and 10% hormone depleted serum. 121 
The Caco-2 cell line (ATCC HTB-37) was routinely grown in DMEM medium, 122 
10% FBS and 1% penicillin streptomycin. 123 
 124 
2.3 Reporter gene assay (RGA). 125 
 RGAs were carried out as previously described by Frizzell et al. (2011). Briefly, 126 
cells were seeded at a concentration of 4 × 10 
5 
cells/ml, 100 μl/well, into white walled 127 
96 well plates with clear flat bottoms (Greiner Bio-One, Germany). The cells were 128 
incubated for 24 h and then exposed to BEA and FB1 (0.001, 0.01, 0.1, 1, 10 μM) for 129 
the agonist test. The positive control used with each cell line was as follows: 1.35 ng/ml 130 
17 β-estradiol (MMV-Luc cells), 14.5 ng/ml testosterone (TARM-Luc cells), 157 ng/ml 131 
progesterone (TM-Luc cells) and 181 ng/ml hydrocortisone (TGRM-Luc cells). A 132 
solvent control 0.5% (v/v) methanol in media was also added to each plate. Antagonist 133 
tests were carried out by incubating BEA and FB1 (0.001, 0.01, 0.1, 1, 10 μM) with the 134 
relevant positive control for each cell line. The cells were incubated for 48 h, after 135 
which, the media was discarded and the cells washed once with phosphate buffered 136 
saline (PBS). The cells were lysed with 30 μl cell culture lysis buffer (Promega, 137 
Southampton, UK) and then 100 μl luciferase (Promega, Southampton, UK) injected 138 
into each well and the response measured using the Mithras Multimode Reader 139 
(Berthold, Other, Germany). The response of the cells to the various compounds was 140 
measured and compared with the solvent control. 141 
 142 
2.4 Cell viability assay 143 
The MTT assay, based on the ability of viable cells to metabolize the yellow 144 
tetrazolium salt to a blue formazan product by the mitochondria, was performed in 145 
parallel to the RGA assays to monitor for cytotoxic effects of the mycotoxins and their 146 
concentrations tested.  147 
Briefly, the cells were exposed exactly as for the RGAs but in clear flat 148 
bottomed 96 well plates (Nunc, Roskilde, Denmark). Following removal of the media, 149 
50 μL of MTT solution (2 mg/ml stock in PBS diluted 1:2.5 in assay media) was added 150 
to each well and incubated for 4 h. The supernatant was removed and 200 L/well of 151 
DMSO added to dissolve the formazan crystals. The absorbance was measured at 152 
570nm and a reference absorbance of 630nm using an automatic plate reader (Tecan, 153 
Safire, USA). Cell viability was calculated as a percentage absorbance of the sample 154 
when compared to the absorbance of the solvent control (0.5% (v/v) methanol in 155 
media).  156 
 157 
2.5 HCA multi-parameter assay  158 
HCA is a rapid and robust technology which can determine multiple cytotoxic 159 
effects, including early (pre-lethal) as well as late-stage occurrences of cytotoxicity 160 
simultaneously. The cytotoxicity of BEA and FB1 was assessed on Caco-2 cells as an 161 
effective indicator of toxicity to the human gut. The TM-Luc cell line was also 162 
investigated by HCA to confirm whether pre-lethal toxicity was inducing the antagonist 163 
response observed at 1 M. 164 
Briefly, cells were seeded at a concentration of 2 × 10
4 
cells/ml, 100 μl/well, into 165 
96 well plates (Nunc, Roskilde, Denmark). The cells were incubated for 24 h and then 166 
exposed to (0.001, 0.01, 0.1, 1, 10 μM) of BEA (TM-Luc cells for 48 h) and BEA or 167 
FB1 (Caco-2 cells for 24 and 48 h).  168 
Cellomics® HCA reagent series multi-parameter cytotoxicity dyes were utilised. 169 
Mitochondrial membrane potential dye was prepared by adding 117 μl of anhydrous 170 
DMSO to make a 1 mM stock. Permeability dye was used as provided in the 171 
multiparameter cytotoxicity 2 multiplex kit (8400202). The live cell staining solution 172 
was prepared by adding 2.1 μl permeability dye to 6 ml of complete media that had 173 
been preheated to 37⁰C, and then 21 μl of mitochondrial membrane potential (final 174 
concentration 3.5 mM). Nuclear stain solution was prepared by adding 5.5 μl Hoechst 175 
33342 dye to 11 ml 1X Wash Buffer. 176 
After incubation, 50 μl of live cell staining solution was added to each well. 177 
Cells were incubated in the dark at 37ºC and 5% CO2 for 30 min. The staining solution 178 
was aspirated and 100 μl of 10% formalin solution (fixation solution) added. The cells 179 
were incubated for 20 min at room temperature before discarding the fixation solution 180 
and washing the cells with 100 μl of PBS. Nuclear staining solution (100 μl) was then 181 
added, and the cells incubated for 10 min at room temperature protected from light.  The 182 
cells were then washed twice and the wells filled with 100 μl of PBS. Cell number 183 
(CN), nuclear area (NA), nuclear intensity (NI), plasma membrane permeability (PMP), 184 
mitochondrial membrane potential (MMP) and mitochondrial mass (MM) were 185 
measured using the CellInsight™ NXT High Content Screening platform (Thermo 186 
Fisher Scientific, UK).  187 
 188 
2.6 Statistical analysis 189 
Assay exposures were carried out in triplicate wells and in three independent 190 
experiments. Results were expressed as the mean ± standard error of the mean (SEM) of 191 
the triplicate exposures.  For the RGAs, data was analysed using Microsoft Excel and 192 
Graphpad PRISM software (San Diego, CA). A one way analysis of variance 193 
(ANOVA) and Dunnett’s multiple comparison test was used to determine significant 194 
differences between the treatments and the corresponding controls in the RGAs, MTT 195 
assays and HCA. The mean concentrations were tested for significant difference at the 196 
95% confidence level. A p value of < 0.05 was considered statistically significant, p = ≤ 197 
0.05 (*), ≤ 0.01 (**) and ≤ 0.001 (***). 198 
 199 
3. Results 200 
3.1. Cell viability 201 
The MTT assay was used to determine the viability of the RGA cells following 202 
exposure to FB1 or BEA (0.001-10 μM). No cytotoxicity was observed in any of the 203 
RGA cell lines exposed to 0.001-10 μM FB1 (Fig.1) or 0.001-1 μM BEA. However, at 204 
10 μM BEA, a decrease in cell viability for all RGA cell lines was observed (p ≤ 0.001) 205 
(Fig. 1).  206 
 207 
3.2. Reporter gene assays 208 
Neither FB1 nor BEA (0.001-10 μM) exhibited an agonist response in any of the 209 
four RGA cell lines (data not shown). However FB1, at the highest concentration tested 210 
(10 μM), exhibited an antagonistic effect (p ≤0.05) on the androgen nuclear receptor 211 
transcriptional activity (Fig. 2b). No antagonist effects were observed in the 212 
progestagen, glucocorticoid or oestrogen RGAs (Fig. 2a, c and d). BEA, at the highest 213 
concentration tested (10 μM), exhibited a strong antagonistic response (p ≤ 0.001) in the 214 
oestrogen, androgen, progestagen and glucocorticoid RGAs (Fig. 3a-d). However, the 215 
MTT assay results indicate that this response is due to the cytotoxicity of BEA at 10 μM 216 
on all of the RGA cell lines. Antagonistic effects on nuclear receptor transcriptional 217 
activity in the progestagen (p ≤ 0.05) and glucocorticoid (p ≤ 0.01) RGAs were also 218 
observed at non-toxic concentrations of 1 μM BEA (Fig. 3c and d). Considering that 219 
BEA is cytotoxic to all of the RGA cell lines at 10 M, it is possible that the antagonism 220 
observed at 1 M BEA is not a true response and instead may be due to pre-lethal 221 
toxicity being initiated within the cells. The validity of this response was further 222 
explored by HCA in the progestagen responsive, TM-Luc cell line. 223 
 224 
3.3 High Content Analysis (HCA). 225 
 In the TM-Luc (progestagen responsive) cell line, BEA (10 μM) was not 226 
possible to analyse due to lethal cytotoxic effects. BEA (1 μM) did not show any 227 
significant differences when compared to the control. Therefore, no pre-lethal toxicity 228 
was observed at 1M BEA, confirming that the antagonism observed in the progestagen 229 
RGA was a true response (Fig. 4).   230 
Exposure of Caco-2 cells to 0.001-10 μM FB1 or BEA revealed that 1 μM BEA 231 
caused a significant (p ≤ 0.01) decrease in the CN (Fig. 5). Nevertheless, 10 μM BEA 232 
was not possible to analyse due to lethal cytotoxic effects on the Caco-2 cells. 233 
 234 
4. Discussion 235 
The MTT assay confirmed that FB1 (0.1 -10 M) was not cytotoxic to any of the 236 
four RGA cell lines. This value is consistent with other publications, Meca et al., (2010) 237 
showed that exposure of Vero cells (monkey kidney) to 0-100 μM FB1 for 24 h 238 
decreased cellular viability to 60 % at 100 μM when compared to the control. In 239 
addition, Wan et al., (2013) did not observed a reduction of viability from 0 to 20 μM 240 
FB1 in IPEC-J2 (porcine jejunal epithelial) cell line after 48 h of exposure. 241 
BEA reduced cell viability at a concentration of 10 μM in all of the RGA and 242 
Caco-2 cell lines. BEA (1 μM) also decreased viability in the Caco-2 cell line upon 48 h 243 
exposure. This data is consistent with previous studies whereby 24 and 48 h 0-30 μM  244 
BEA exposure of Caco-2 cells decreased viability to 80% and 87% respectively and 245 
HT-29 (human colon adenocarcinoma) cells presented a decrease of 85% at 24 h and 246 
90% at 48 h ( Prosperini et al., 2012). Similar results were obtained by Calo et al. 247 
(2004) with two human cell lines of myeloid origin (U-937 and HL-60 cells) and Ferrer 248 
et al. (2009) who investigated 0-100 μM BEA exposure on Chinese hamster ovary cells 249 
(CHO-K1). They observed a decline in viability at a concentration of 10 μM or higher 250 
after 24 h. 251 
The application of HCA in toxicity studies is based on the parallel analysis of 252 
multiple markers for cytotoxicity, which allows early reversible and late irreversible 253 
effects to be distinguished, and thus provides a more detailed analysis of compound-254 
induced toxicity (Ramirez et al. 2010; Tolosa et al., 2015). In this context, HCA can 255 
identify gross toxicity and pre-lethal toxicity, whereby exposed cells are not dead but 256 
are becoming unhealthy. While traditional end-point toxicity assays such as MTT can 257 
identify gross toxicity, they cannot do so for pre-lethal toxicity. 258 
In the current study, an antagonist response was observed in the progesterone 259 
responsive TM-Luc cell line after exposure to 1 M BEA. While the MTT assay was 260 
able to confirm cytotoxicity via BEA exposure at 10 M but not at 1 M, the potential 261 
for pre-lethal toxicity being responsible for the perceived antagonist response was 262 
considered. Consequently, HCA analysis was utilised to confirm the absence of pre-263 
lethal toxicity and thus confirm the validity of the progesterone receptor antagonist 264 
response.  265 
The Caco-2 cell line is a well-recognised human gut cell model (Sambuy et al., 266 
2004) and as such is suited to investigating the toxic effects of food contaminants. HCA 267 
analysis confirmed that FB1 was not cytotoxic at any of the concentrations tested on the 268 
Caco-2 cell line. However, BEA exhibited cytotoxicity at 1 M on the Caco-2 cell line. 269 
Furthermore, in this study was observed a slight decrease in MMP at 1 M BEA. 270 
According to Jow et al. (2004), Ca2+-dependent pathway by BEA involves cell death, 271 
in which it induced an increase in intracellular [Ca2+] that leads to a combination of 272 
cellular apoptosis and necrosis responses. Moreover, Tonshin et al., (2010) in isolated 273 
mitochondria BEA induced a loss of MMP where K+ inflow into the mitochondrial 274 
matrix and uncoupling of oxidative phosphorylation, followed by induction of 275 
apoptosis. In addition, Prosperini et al., (2013)  investigated that Caco-2 cells exhibit 276 
mitochondrial dysfunction leading a stable depolarized state of MMP and cell death 277 
after exposure of 1.5 and 3 M BEA. Low BEA concentrations might be reached due to 278 
food consumption and based on tissue accumulation (Jestoi et al., 2007). Moreover, 279 
with regard to food intake, BEA might increase the absorption of commonly co-280 
occurring mycotoxins probably leading to higher toxicity. Thus, exposure to low BEA 281 
concentrations activates diverse cellular stress response and protection systems 282 
(Mallebrera et al., 2014). This indicates that continuous exposure to BEA might lead to 283 
alter the intestinal epithelial barrier (Dornetshuber et al., 2009). 284 
Antagonism of the androgen receptor in the TARM-Luc cell line was observed 285 
following exposure to 10 μM FB1. A reduction in the transcriptional activity of the 286 
androgen, glucocorticoid, oestrogen and progestagen receptor was correlated to the 287 
cytotoxic effects of BEA at 10 μM rather than true antagonism. An antagonistic 288 
response was also observed in the TGRM-Luc (glucocorticoid) and TM-Luc 289 
(progesterone) cell lines following exposure to 1 μM BEA. HCA established that no 290 
pre-lethal toxicity was evident in the TM-Luc cell line at 1 μM BEA and thus the 291 
reduction in progesterone receptor transcriptional activity was confirmed as a true 292 
antagonist response. To the authors’ knowledge, this is the first study investigating the 293 
endocrine disrupting effects of FB1 and BEA at the level of nuclear receptor activity.  294 
The actions of progesterone, glucocorticoid and androgen are mediated by its receptor. 295 
In the target cell, progesterone, glucocorticoid and androgen produce a change in 296 
conformation of its receptors that is associated with transforming receptors from a non-297 
DNA binding form to one that will bind to DNA (Spitz et al., 2003). This 298 
transformation is go with a loss of associated heat shock proteins and dimerization. The 299 
activated receptors dimers then binds to specific DNA sequences within the promotor 300 
region of progesterone, glucocorticoid and androgen responsive genes. Antagonist 301 
impair the ability of receptors to interact with coactivators allowing the recruitment of 302 
corepressors (Liu et al., 2002). The antagonist activity of an antihormone may depend 303 
on the cell or tissue type. In addition, these transformations in the structure and function 304 
of the receptor results in numerous endocrine disorders. Many antagonists of 305 
progesterone receptor display antiproliferative effects in the endometrium by 306 
suppressing follicular development and blocking the LH flood. Moreover, progesterone 307 
antagonists are potent antiglucocorticoid agents (Neulen et al., 1996). GR signalling is 308 
requiered for homeostatic control of pyramidal neurons. Thus, GR hormone influence 309 
memory, mood, and neuronal survival (Savory et al., 2001) Therefore, inhibition of the 310 
GR may affect the peripheral glucose metabolism, the stress response, and the 311 
regulation of the hypothalamic pituitary axis (Honer et al., 2003; Deroche-Gamonet et 312 
al., 2003). The regulatory steroidal sex hormones role in developmental processes such 313 
as sex determination and differentiation is of particular interest with regard to endocrine 314 
disruption (Kelce et al., 1995; 1997). Androgens, through interaction with the androgen 315 
receptor, play decisive roles in sexual differentiation of the male reproductive tract, 316 
accessory reproductive organs, and other tissues during fetal development. They also 317 
influence male pubertal maturation and the maintenance of secondary sex characteristics 318 
in adults. (Wilson et al., 2001) 319 
This in vitro investigation has demonstrated the potential for FB1 and BEA to 320 
modulate the endocrine system by antagonism of nuclear transcriptional activity as 321 
observed for BEA (1 μM) on the glucocorticoid and progesterone receptor and FB1 (10 322 
μM) on the androgen receptor. HCA has also proven to be an added value cytotoxic 323 
assessment tool in establishing pre-lethal toxicity in exposed cells and confirming 324 
antagonistic responses. In addition, while FB1 did not show any significant cytotoxic 325 
effects on mammalian gut cells, BEA did at a concentration of 1 M.  Further 326 
investigation is needed to investigate the risk of BEA and FB1 exposure in humans and 327 
animals. 328 
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Legends of Figures: 484 
 485 
Fig.1 Viability of the RGA cell lines a) MMV-Luc b) TARM-Luc c) TM-Luc and d) 486 
TGRM-Luc following exposure to 0.001-10 μM of FB1 and BEA for 48 h and 487 
compared to the solvent control, as determined in the MTT assay. Values are means ± 488 
SEM for the three separate experiments (n=3), p ≤ 0.001 (***). 489 
 490 
Fig.2 Results of RGA antagonistic test following co-exposure of the positive control 491 
with FB1 (0.001-10 μM) in the a) MMV-Luc (oestrogen responsive), b) TARM-Luc 492 
(androgen responsive), c) TM-Luc (progestagen responsive) and d) TGRM-Luc 493 
(glucocorticoid responsive) RGA cells. Responses measured are compared to the 494 
solvent and the positive control (1.36 ng/ml 17 β-estradiol, 14.5 ng/ml testosterone, 157 495 
ng/ml progesterone and 181 ng/ml cortisol, respectively). Results are expressed as the 496 
mean percentage response ± SEM for the three separate experiments (n=3), p ≤ 0.05 (*). 497 
 498 
Fig.3 Results of RGA antagonistic test following co-exposure of the positive control 499 
with BEA (0.001-10 μM) in the a) MMV-Luc (estrogen responsive), b) TARM-Luc 500 
(androgen responsive), c) TM-Luc (progestagen responsive) and d) TGRM-Luc 501 
(glucocorticoid responsive) RGA cells. Responses measured are compared to the 502 
solvent and relevant positive controls (1.36 ng/ml 17 β-estradiol, 14.5 ng/ml 503 
testosterone, 157 ng/ml progesterone and 181 ng/ml cortisol, respectively). Responses 504 
are expressed as the mean percentage response ± SEM for the three separate 505 
experiments (n=3), p ≤ 0.05 (*), ≤ 0.01 (**), ≤ 0.001 (***). 506 
 507 
Fig.4 Quantification of the cytotoxic effects of 0.001-1 μM BEA in the progestagen 508 
responsive TM-Luc cells as measured by HCA. a) cell number (CN) b) nuclear area 509 
(NA), c) nuclear intensity (NI), d) plasma membrane permeability (PMP), e) 510 
mitochondrial membrane potential (MMP) and f) mitochondrial mass (MM). Data are 511 
expressed as mean values ± SEM for the three separate experiments (n=3). p ≤ 0.05 (*) 512 
and p ≤ 0.01(**) indicate significant differences from the solvent control. 513 
 514 
Fig.5 Quantification of the cytotoxic effects of 0.001-10 μM FB1 and BEA in the gut 515 
derived Caco-2 cells after 48 h exposure as measured by HCA. a) cell number (CN) b) 516 
nuclear area (NA), c) nuclear intensity (NI), d) plasma membrane permeability (PMP), 517 
e) mitochondrial membrane potential (MMP) and f) mitochondrial mass (MM). Data are 518 
expressed as mean values ± SEM for the three separate experiments (n=3). p ≤ 0.001 519 
(***)indicate significant differences from the solvent control. 520 
 521 
 522 
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